XML 13 R6.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - USD ($)
Total
Common Stock
Additional Paid-in Capital [Member]
Accumulated Comprehensive Income [Member]
Accumulated Deficit [Member]
Treasury Stock [Member]
Beginning balance at Dec. 31, 2022 $ 6,359,365 $ 775 $ 95,105,071 $ 43,227 $ (88,783,244) $ (6,464)
Beginning balance, shares at Dec. 31, 2022   7,750,635       27
Proceeds from sale of common stock in public offering costs, value 3,616,094 $ 1,317 3,614,777      
Proceeds from sale of common stock in public offering costs, shares   13,169,074        
Proceeds from sale of pre-funded warrants, value 2,064,012   2,064,012      
Common stock issued upon vesting of restricted stock units, Shares   2,821        
Stock-based compensation 171,027   171,027      
Other comprehensive (loss)/income 65,788     65,788    
Net Income (Loss) (2,644,295)       (2,644,295)  
Ending balance at Mar. 31, 2023 9,631,991 $ 2,092 100,954,887 109,015 (91,427,539) $ (6,464)
Ending balance, shares at Mar. 31, 2023   20,922,530       27
Beginning balance at Dec. 31, 2022 6,359,365 $ 775 95,105,071 43,227 (88,783,244) $ (6,464)
Beginning balance, shares at Dec. 31, 2022   7,750,635       27
Net Income (Loss) (5,687,461)          
Ending balance at Sep. 30, 2023 11,023,111 $ 2,652 105,506,182 (8,554) (94,470,705) $ (6,464)
Ending balance, shares at Sep. 30, 2023   26,515,462       27
Beginning balance at Mar. 31, 2023 9,631,991 $ 2,092 100,954,887 109,015 (91,427,539) $ (6,464)
Beginning balance, shares at Mar. 31, 2023   20,922,530       27
Common stock issued upon vesting of restricted stock units (8,147) $ 18 (8,165)      
Common stock issued upon vesting of restricted stock units, Shares   169,499        
Stock-based compensation 280,061   280,061      
Unrealized gains (loss) on foreign currency adjustments (71,357)     (71,357)    
Other comprehensive (loss)/income 1,634     1,634    
Net Income (Loss) (1,014,150)       (1,014,150)  
Ending balance at Jun. 30, 2023 8,820,032 $ 2,110 101,226,783 39,292 (92,441,689) $ (6,464)
Ending balance, shares at Jun. 30, 2023   21,092,029       27
Proceeds from sale of common stock in public offering costs, value 2,915,588 $ 541 2,915,047      
Proceeds from sale of common stock in public offering costs, shares   5,413,334        
Proceeds from sale of pre-funded warrants, value 1,033,928   1,033,928      
Common stock issued upon vesting of restricted stock units 31 $ 1 30      
Common stock issued upon vesting of restricted stock units, Shares   10,099        
Stock-based compensation 330,394   330,394      
Other comprehensive (loss)/income (47,846)     (47,846) (0)  
Net Income (Loss) (2,029,016)       (2,029,016)  
Ending balance at Sep. 30, 2023 11,023,111 $ 2,652 105,506,182 (8,554) (94,470,705) $ (6,464)
Ending balance, shares at Sep. 30, 2023   26,515,462       27
Beginning balance at Dec. 31, 2023 8,989,350 $ 2,715 105,840,239 83,669 (96,930,809) $ (6,464)
Beginning balance, shares at Dec. 31, 2023   27,135,061       27
Proceeds from sale of common stock in public offering costs, value 4,598,771 $ 135 4,598,636      
Proceeds from sale of common stock in public offering costs, shares   1,354,218        
Proceeds from sale of pre-funded warrants, value 763,138   763,138      
Common stock issued upon vesting of restricted stock units   $ 31 (31)      
Common stock issued upon vesting of restricted stock units, Shares   300,544        
Stock-based compensation 320,288   320,288      
Other comprehensive (loss)/income 63,842     63,842    
Net Income (Loss) (3,835,632)       (3,835,632)  
Ending balance at Mar. 31, 2024 10,899,757 $ 2,881 111,522,270 147,511 (100,766,441) $ (6,464)
Ending balance, shares at Mar. 31, 2024   28,789,823       27
Beginning balance at Dec. 31, 2023 8,989,350 $ 2,715 105,840,239 83,669 (96,930,809) $ (6,464)
Beginning balance, shares at Dec. 31, 2023   27,135,061       27
Net Income (Loss) (5,923,648)          
Ending balance at Sep. 30, 2024 9,292,334 $ 3,025 111,754,495 395,734 (102,854,457) $ (6,464)
Ending balance, shares at Sep. 30, 2024   30,244,182       27
Beginning balance at Mar. 31, 2024 10,899,757 $ 2,881 111,522,270 147,511 (100,766,441) $ (6,464)
Beginning balance, shares at Mar. 31, 2024   28,789,823       27
Exercise of pre-funded warrants, value 77 $ 77        
Exercise of pre-funded warrants, share   774,730        
Common stock issued upon vesting of restricted stock units   $ 63 (63)      
Common stock issued upon vesting of restricted stock units, Shares   636,801        
Stock-based compensation (91,893)   (91,893)      
Other comprehensive (loss)/income (8,623)     (8,623)    
Net Income (Loss) (1,121,607)       (1,121,607)  
Ending balance at Jun. 30, 2024 9,677,711 $ 3,021 $ 111,430,314 138,888 (101,888,048) $ (6,464)
Ending balance, shares at Jun. 30, 2024   30,201,354       27
Common stock issued upon vesting of restricted stock units   $ 4        
Common stock issued upon vesting of restricted stock units, Shares   42,828 (4)      
Stock-based compensation 324,185   $ 324,185    
Other comprehensive (loss)/income 256,846     256,846    
Net Income (Loss) (966,409)       (966,409)  
Ending balance at Sep. 30, 2024 $ 9,292,334 $ 3,025 $ 111,754,495 $ 395,734 $ (102,854,457) $ (6,464)
Ending balance, shares at Sep. 30, 2024   30,244,182       27